Loading…
Operates in Healthcare Services — Other healthcare services. Per the activity note to the FY2024 annual report, the company provides international healthcare services. Founded 19 May 2010.
| Ratio | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Margins | ||||||
| Gross Margin | 95.6% | 92.2% | 100.0% | 100.0% | 100.0% | 96.9% |
| EBITDA Margin | 18.8% | -188.7% | -211.1% | -80.1% | -8.8% | -46.2% |
| EBITDAR | 636 | -1,305 | -1,218 | -937 | -59 | -831 |
| EBITDAR Margin | 23.6% | -166.7% | -191.1% | -70.5% | -2.5% | -38.5% |
| EBIT Margin | 18.2% | -191.3% | -214.3% | -81.7% | -10.0% | -47.6% |
| Net Profit Margin | 22.9% | -160.0% | -221.7% | -108.3% | -18.0% | -43.7% |
| Operating Expense % of Sales | 76.9% | 280.9% | 311.1% | 180.1% | 108.8% | 143.1% |
| Returns | ||||||
| Return on Assets (ROA) | 23.6% | -65.4% | -124.2% | -32.8% | -10.1% | -53.3% |
| Return on Equity (ROE) | 57.1% | -731.0% | N/A | N/A | N/A | N/A |
| ROIC [EBIT / Invested Capital] | N/A | N/A | N/A | N/A | N/A | N/A |
| Leverage & debt balances | ||||||
| Debt-to-Assets | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Debt-to-Equity | 0.00x | 0.00x | -0.00x | -0.00x | -0.00x | -0.00x |
| Debt-to-EBITDA | 0.00x | N/A | N/A | N/A | N/A | N/A |
| Equity-to-Assets | 41.4% | 9.0% | -107.0% | -60.6% | -74.7% | -226.5% |
| Net Debt | -2,369 | -1,148 | -565 | -3,685 | -1,566 | -406 |
| Cash & Equivalents | 2,369 | 1,148 | 565 | 3,685 | 1,566 | 406 |
| Total Debt | N/A | N/A | N/A | N/A | N/A | N/A |
| Liquidity & working capital | ||||||
| Current Ratio | 0.05x | 0.25x | 0.18x | 0.07x | 0.09x | 0.09x |
| Quick Ratio | 0.05x | 0.25x | 0.18x | 0.07x | 0.09x | 0.09x |
| Cash Ratio | 1.55x | 0.68x | 0.24x | 0.52x | 0.22x | 0.07x |
| Total Current Assets | 80 | 418 | 418 | 520 | 631 | 506 |
| Total Current Liabilities | 1,532 | 1,695 | 2,319 | 7,043 | 7,182 | 5,789 |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A |
| Trade Receivables | 3 | 3 | 3 | 3 | 3 | 72 |
| Trade Payables | 48 | 315 | 454 | 1,031 | 1,904 | 2,191 |
| Net Working Capital | -1,452 | -1,277 | -1,901 | -6,523 | -6,551 | -5,283 |
| Net Working Capital % of Revenue | -53.8% | -163.1% | -298.3% | -490.9% | -284.6% | -244.5% |
| Trade Working Capital | -45 | -311 | -451 | -1,028 | -1,901 | -2,119 |
| Trade Working Capital % of Revenue | -1.7% | -39.8% | -70.8% | -77.3% | -82.6% | -98.1% |
| Change in Trade Working Capital | N/A | -267 | -139 | -577 | -874 | -218 |
| Turnover & efficiency | ||||||
| Inventory Turnover | N/A | N/A | N/A | N/A | N/A | N/A |
| Days Inventory Outstanding (DIO) | N/A | N/A | N/A | N/A | N/A | N/A |
| Receivables Turnover | 856.22x | 248.58x | 202.31x | 421.86x | 730.66x | 29.98x |
| Days Sales Outstanding (DSO) | 0.4 | 1.5 | 1.8 | 0.9 | 0.5 | 12.2 |
| Payables Turnover | 2.46x | 0.19x | N/A | N/A | N/A | 0.03x |
| Days Payable Outstanding (DPO) | 148.2 | 1880.3 | N/A | N/A | N/A | 11777.8 |
| Cash Conversion Cycle | -147.8 days | -1878.8 days | 1.8 days | 0.9 days | 0.5 days | -11765.6 days |
| Asset Turnover | 1.03x | 0.41x | 0.56x | 0.30x | 0.56x | 1.22x |
| Cash flow & dividends | ||||||
| Operating Cash Flow | 621 | -1,221 | -583 | 3,120 | -2,119 | -2,498 |
| Free Cash Flow (OCF − Capex proxy) | 621 | -1,221 | -583 | 3,120 | -2,119 | -2,498 |
| Cash Conversion (OCF / EBITDA) | 122.8% | N/A | N/A | N/A | N/A | N/A |
| Dividends Declared | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividend Payout Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in GEL, thousands. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →